4suxxess welcomes you!

Setup. Growth. Restructuring. Turnaround.


At 4suxxess, we offer you a team of business architects dedicated to support your company with services designed to enable you to enhance your competitiveness - whether it’s overcoming barriers to success or developing markets locally and globally.

4suxxess provides experienced executive professionals, with the right skill sets to ensure success in challenging assignments and projects.

PharmaTimes: News RSS

Medicines Discovery Catapult, ANTRUK start antibiotics project (Fri, 20 Oct 2017)
A new research project has begun at Warwick University striving to tackle antimicrobial resistance, one of the fastest growing health problems around the globe.
>> Read More

National PreP service would be cost effective, research finds (Fri, 20 Oct 2017)
Providing pre-exposure prophylaxis (PrEP) treatment to men who have sex with men at high risk of contracting HIV in England would be cost-effective and could prevent 25 percent of cases of infection, according to UCL research.
>> Read More

Celgene pulls plug on Crohn’s disease trials (Fri, 20 Oct 2017)
Celgene is abandoning late-stage testing of its experimental drug mongersen for Crohn’s disease after a Data Monitoring Committee concluded that it would be futile to continue.
>> Read More

NICE no for Opdivo in urothelial carcinoma (Fri, 20 Oct 2017)
The National Institute for Health and Care Excellence has published draft guidelines rejecting NHS funding for Bristol-Myers Squibb’s Opdivo as a treatment for locally advanced unresectable or metastatic urothelial carcinoma (mUC).
>> Read More

Allergy Therapeutics kicks off dosing in grass immunotherapy trial (Thu, 19 Oct 2017)
Allergy Therapeutics has begun dosing in a mid-stage trial designed to assess the dose-response and safety of its ultra-short course PQ Grass immunotherapy, which targets the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen.
>> Read More